Peripheral arterial disease in HIV-infected and uninfected women

Anjali Sharma, S. Holman, R. Pitts, H. L. Minkoff, J. A. Dehovitz, J. Lazar

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective: Although HIV infection has been associated with increased risk of subclinical atherosclerosis and cardiovascular events, peripheral arterial disease (PAD) has not been assessed in HIV-infected patients. The objective of this study was to determine the prevalence of, and risk factors for, PAD using ankle-brachial index (ABI) measurement in HIV-infected and uninfected women. Methods: ABI was determined for 335 participants in the Women's Interagency HIV Study (WIHS). A cross-sectional analysis was conducted to determine factors associated with high (≥1.40) ABI. Results: The prevalence of low ABI (≤0.9) was 0.9% (n = 3) and the prevalence of high ABI (≥1.40) was 6.9% (n = 23). The prevalence of low ABI was too low to allow risk factor analysis. On multivariate analysis, factors associated with high ABI were current cigarette smoking [adjusted odds ratio (OR adj) 2.53, 95% confidence interval (CI) 0.99-6.43], being underweight (OR adj 11.0, 95% CI 1.61-75.63) and being overweight (OR adj 5.40, 95% CI 1.13-25.89). Conclusions: Although the prevalence of ABI ≤0.9 was low in this cohort of HIV-infected and uninfected women, the prevalence of ABI ≥1.40 was unexpectedly high. Further studies are indicated to determine the clinical significance of high ABI and its relation to the risk of cardiovascular events in HIV-infected women.

Original languageEnglish (US)
Pages (from-to)555-560
Number of pages6
JournalHIV Medicine
Volume8
Issue number8
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Ankle Brachial Index
Peripheral Arterial Disease
HIV
Confidence Intervals
Thinness
Statistical Factor Analysis
HIV Infections
Atherosclerosis
Multivariate Analysis
Cross-Sectional Studies
Smoking
Odds Ratio

Keywords

  • Ankle-brachial index
  • HIV
  • Peripheral arterial disease
  • Women

ASJC Scopus subject areas

  • Virology
  • Medicine(all)
  • Immunology

Cite this

Sharma, A., Holman, S., Pitts, R., Minkoff, H. L., Dehovitz, J. A., & Lazar, J. (2007). Peripheral arterial disease in HIV-infected and uninfected women. HIV Medicine, 8(8), 555-560. https://doi.org/10.1111/j.1468-1293.2007.00509.x

Peripheral arterial disease in HIV-infected and uninfected women. / Sharma, Anjali; Holman, S.; Pitts, R.; Minkoff, H. L.; Dehovitz, J. A.; Lazar, J.

In: HIV Medicine, Vol. 8, No. 8, 11.2007, p. 555-560.

Research output: Contribution to journalArticle

Sharma, A, Holman, S, Pitts, R, Minkoff, HL, Dehovitz, JA & Lazar, J 2007, 'Peripheral arterial disease in HIV-infected and uninfected women', HIV Medicine, vol. 8, no. 8, pp. 555-560. https://doi.org/10.1111/j.1468-1293.2007.00509.x
Sharma, Anjali ; Holman, S. ; Pitts, R. ; Minkoff, H. L. ; Dehovitz, J. A. ; Lazar, J. / Peripheral arterial disease in HIV-infected and uninfected women. In: HIV Medicine. 2007 ; Vol. 8, No. 8. pp. 555-560.
@article{54ff206cd1a64987a1e5a3d8688bb004,
title = "Peripheral arterial disease in HIV-infected and uninfected women",
abstract = "Objective: Although HIV infection has been associated with increased risk of subclinical atherosclerosis and cardiovascular events, peripheral arterial disease (PAD) has not been assessed in HIV-infected patients. The objective of this study was to determine the prevalence of, and risk factors for, PAD using ankle-brachial index (ABI) measurement in HIV-infected and uninfected women. Methods: ABI was determined for 335 participants in the Women's Interagency HIV Study (WIHS). A cross-sectional analysis was conducted to determine factors associated with high (≥1.40) ABI. Results: The prevalence of low ABI (≤0.9) was 0.9{\%} (n = 3) and the prevalence of high ABI (≥1.40) was 6.9{\%} (n = 23). The prevalence of low ABI was too low to allow risk factor analysis. On multivariate analysis, factors associated with high ABI were current cigarette smoking [adjusted odds ratio (OR adj) 2.53, 95{\%} confidence interval (CI) 0.99-6.43], being underweight (OR adj 11.0, 95{\%} CI 1.61-75.63) and being overweight (OR adj 5.40, 95{\%} CI 1.13-25.89). Conclusions: Although the prevalence of ABI ≤0.9 was low in this cohort of HIV-infected and uninfected women, the prevalence of ABI ≥1.40 was unexpectedly high. Further studies are indicated to determine the clinical significance of high ABI and its relation to the risk of cardiovascular events in HIV-infected women.",
keywords = "Ankle-brachial index, HIV, Peripheral arterial disease, Women",
author = "Anjali Sharma and S. Holman and R. Pitts and Minkoff, {H. L.} and Dehovitz, {J. A.} and J. Lazar",
year = "2007",
month = "11",
doi = "10.1111/j.1468-1293.2007.00509.x",
language = "English (US)",
volume = "8",
pages = "555--560",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Peripheral arterial disease in HIV-infected and uninfected women

AU - Sharma, Anjali

AU - Holman, S.

AU - Pitts, R.

AU - Minkoff, H. L.

AU - Dehovitz, J. A.

AU - Lazar, J.

PY - 2007/11

Y1 - 2007/11

N2 - Objective: Although HIV infection has been associated with increased risk of subclinical atherosclerosis and cardiovascular events, peripheral arterial disease (PAD) has not been assessed in HIV-infected patients. The objective of this study was to determine the prevalence of, and risk factors for, PAD using ankle-brachial index (ABI) measurement in HIV-infected and uninfected women. Methods: ABI was determined for 335 participants in the Women's Interagency HIV Study (WIHS). A cross-sectional analysis was conducted to determine factors associated with high (≥1.40) ABI. Results: The prevalence of low ABI (≤0.9) was 0.9% (n = 3) and the prevalence of high ABI (≥1.40) was 6.9% (n = 23). The prevalence of low ABI was too low to allow risk factor analysis. On multivariate analysis, factors associated with high ABI were current cigarette smoking [adjusted odds ratio (OR adj) 2.53, 95% confidence interval (CI) 0.99-6.43], being underweight (OR adj 11.0, 95% CI 1.61-75.63) and being overweight (OR adj 5.40, 95% CI 1.13-25.89). Conclusions: Although the prevalence of ABI ≤0.9 was low in this cohort of HIV-infected and uninfected women, the prevalence of ABI ≥1.40 was unexpectedly high. Further studies are indicated to determine the clinical significance of high ABI and its relation to the risk of cardiovascular events in HIV-infected women.

AB - Objective: Although HIV infection has been associated with increased risk of subclinical atherosclerosis and cardiovascular events, peripheral arterial disease (PAD) has not been assessed in HIV-infected patients. The objective of this study was to determine the prevalence of, and risk factors for, PAD using ankle-brachial index (ABI) measurement in HIV-infected and uninfected women. Methods: ABI was determined for 335 participants in the Women's Interagency HIV Study (WIHS). A cross-sectional analysis was conducted to determine factors associated with high (≥1.40) ABI. Results: The prevalence of low ABI (≤0.9) was 0.9% (n = 3) and the prevalence of high ABI (≥1.40) was 6.9% (n = 23). The prevalence of low ABI was too low to allow risk factor analysis. On multivariate analysis, factors associated with high ABI were current cigarette smoking [adjusted odds ratio (OR adj) 2.53, 95% confidence interval (CI) 0.99-6.43], being underweight (OR adj 11.0, 95% CI 1.61-75.63) and being overweight (OR adj 5.40, 95% CI 1.13-25.89). Conclusions: Although the prevalence of ABI ≤0.9 was low in this cohort of HIV-infected and uninfected women, the prevalence of ABI ≥1.40 was unexpectedly high. Further studies are indicated to determine the clinical significance of high ABI and its relation to the risk of cardiovascular events in HIV-infected women.

KW - Ankle-brachial index

KW - HIV

KW - Peripheral arterial disease

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=35448949149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448949149&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1293.2007.00509.x

DO - 10.1111/j.1468-1293.2007.00509.x

M3 - Article

C2 - 17944689

AN - SCOPUS:35448949149

VL - 8

SP - 555

EP - 560

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 8

ER -